[1]
S. Narayan Singh, “Comparing the effect of Alpha blocker (Silodosin) and Phosphodiesterase type 5 inhibitor (Tadalafil) in benign prostate hyperplasia patients with lower urinary tract symptoms: a single centre study”, Int Surg J, vol. 5, no. 5, pp. 1866–1872, Apr. 2018.